He encontrado que alguna farmacia puede tener existencias limitadas de ciertos medicamentos, mientras que otras pueden tener casi cualquier formato que se le ocurra y el habitual de dosis habitualidad apareció. En resumen, siempre se contiene el almacén de corroborar. Al mismo tiempo que el producto que más que gustaba ha resultado no estaba disponible en stock otro distinto por las Buenas costumbres también debe buscarse jefe no asн parezca. Por eso es importante disponer de un Plan B para actuar cuandod ello no ocurra.
Ventaja de tomar un genérico en lugar de Asix
Un genérico es más barato que el nombre de marca
Uno de los mayores incentivos para someterse al Dónde comprar Lasix genérico en lugar de pagar la marca es que usted puede obtener un ahorrando importantes Lasix genérico. Por lo tanto, un Lasix genérico es en general mucho más barato que el homólogo de marca, así que una denominación genérica se hace posible para las personas que usan este medicamento con frecuencia. Un ejemplo: La compra de lurosemida en lugar de Lasix es una considerable ahorro para el presupuesto mensual de medicamentos.
Microsoft word - atsdr mrls - february 2013.docx
Agency for Toxic Substances and Disease Registry
MINIMAL RISK LEVELS (MRLs)
February 2013
Uncertainty
Name Route tion MRL Factors Endpoint Status Date Number ______________________________________________________________________________________________________________ ACENAPHTHENE Oral Int. 0.6 mg/kg/day 300 Hepatic Final 08/95 83-32-9 ACETONE Inh. Acute 26 ppm 9 Neurol. Final 05/94 67-64-1 Int. 13 ppm 100 Neurol. Chr. 13 ppm 100 Neurol. Oral Int. 2 mg/kg/day 100 Hemato. ACROLEIN Inh. Acute 0.003 ppm 100 Resp. Final 08/07 107-02-8 Int. 0.00004 ppm 300 Resp. Oral Int. 0.004 mg/kg/day 100 Gastro. ACRYLAMIDE Oral Acute 0.01 mg/kg/day 30 Repro. Final 12/12 79-06-1 Int. 0.001 mg/kg/day 30 Neurol. Chr. 0.001 mg/kg/day 30 Neurol. ACRYLONITRILE Inh. Acute 0.1 ppm 10 Neurol. Final 12/90 107-13-1 Oral Acute 0.1 mg/kg/day 100 Develop. Int. 0.01 mg/kg/day 1000 Repro. Chr. 0.04 mg/kg/day 100 Hemato. ALDRIN Oral Acute 0.002 mg/kg/day 1000 Develop. Final 09/02 309-00-2 Chr. 0.00003 mg/kg/day 1000 Hepatic ALUMINUM Oral Int. 1.0 mg/kg/day 30 Neurol. Final 09/08 7429-90-5 Chr. 1.0 mg/kg/day 90 Neurol. AMERICIUM Rad. Acute 4 mSv 3 Develop. Final 10/04 7440-35-9 Chr. 1 mSv/yr 3 Other AMMONIA Inh. Acute 1.7 ppm 30 Resp. Final 10/04 7664-41-7 Chr. 0.1 ppm 30 Resp. ANTHRACENE Oral Int. 10 mg/kg/day 100 Hepatic Final 08/95 120-12-7
Oral Acute 0.005 mg/kg/day 10 Gastro. Final 08/07 7440-38-2
Chr. 0.0003 mg/kg/day 3 Dermal ATRAZINE Oral Acute
0.01 mg/kg/day
100 Body Wt. Final 09/03 1912-24-9
Int. 0.003 mg/kg/day 300 Repro.
BARIUM, SOLUBLE SALTS
0.2 mg/kg/day
100 Renal
7440-39-3
0.2 mg/kg/day
100 Renal
Inh. Acute
0.009 ppm
300 Immuno. Final 08/07 71-43-2
0.006 ppm
300 Immuno.
0.003 ppm
10 Immuno.
0.0005 mg/kg/day
30 Immuno.
BERYLLIUM
0.002 mg/kg/day
300 Gastro. Final
7440-41-7
BIS(2-CHLOROETHYL) ETHER
1000 Body Wt. Final
111-44-4
BIS(CHLOROMETHYL) ETHER
0.0003 ppm
100 Resp.
542-88-1
Inh. Acute
0.3 mg/m3
7440-42-8
Oral Acute
0.2 mg/kg/day
100 Develop.
0.2 mg/kg/day
66 Develop.
BROMODICHLOROMETHANE
Oral Acute
0.04 mg/kg/day
1000 Hepatic Final
0.02 mg/kg/day
1000 Renal
BROMOFORM
Oral Acute
0.7 mg/kg/day
100 Hepatic Final
0.2 mg/kg/day
300 Hepatic
0.02 mg/kg/day
3000 Hepatic
BROMOMETHANE
Inh. Acute
100 Neurol. Final
100 Neurol.
0.005 ppm
100 Neurol.
0.003 mg/kg/day
100 Gastro.
2-BUTOXYETHANOL
Inh. Acute
Hemato. Final
111-76-2
(ETHYLENE GLYCOL MONOBUTYL ETHER)
9 Hemato.
3 Hemato.
Oral Acute
0.4 mg/kg/day
90 Hemato.
0.07 mg/kg/day
1000 Hepatic
Inh. Acute
0.00003 mg/m3
300 Resp.
7440-43-9
0.00001 mg/m3
Oral Int. 0.0005 mg/kg/day 100 Musculo. Chr. 0.0001 mg/kg/day 3 Renal CARBON DISULFIDE Inh. Chr. 0.3 ppm 30 Neurol. Final 08/96 75-15-0 Oral Acute 0.01 mg/kg/day 300 Hepatic CARBON TETRACHLORIDE Inh. Int. 0.03 ppm 30 Hepatic Final 09/05 56-23-5 Chr. 0.03 ppm 30 Hepatic Oral Acute 0.02 mg/kg/day 300 Hepatic Int. 0.007 mg/kg/day 100 Hepatic CESIUM Rad. Acute 4 mSv 3 Develop. Final 10/04 7440-46-2 Chr. 1 mSv/yr 3 Other CHLORDANE Inh. Int. 0.0002 mg/m3 100 Hepatic Final 05/94 57-74-9 Chr. 0.00002 mg/m3 1000 Hepatic Oral Acute 0.001 mg/kg/day 1000 Develop. Int. 0.0006 mg/kg/day 100 Hepatic Chr. 0.0006 mg/kg/day 100 Hepatic CHLORDECONE Oral Acute 0.01 mg/kg/day 100 Neurol. Final 08/95 143-50-0 Int.
0.0005 mg/kg/day
100 Renal
0.0005 mg/kg/day
100 Renal
CHLORFENVINPHOS Oral Acute 0.002 mg/kg/day 1000 Neurol. Final 09/97 470-90-6 Int. 0.002 mg/kg/day 1000 Immuno. Chr.
0.0007 mg/kg/day
1000 Neurol.
CHLORINE
Inh. Acute
Final 11/10 7782-50-5
0.002 ppm
0.00005 ppm
CHLORINE DIOXIDE
0.001 ppm
300 Resp.
10/04 10049-04-4
CHLORITE
0.1 mg/kg/day
30 Neurol. Final
7758-19-2
CHLOROBENZENE
0.4 mg/kg/day
100 Hepatic Final
108-90-7
CHLORODIBROMOMETHANE
Oral Acute
0.1 mg/kg/day
300 Hepatic Final
124-48-1
0.09 mg/kg/day
300 Hepatic
CHLOROETHANE
Inh. Acute
100 Develop. Final
CHLOROFORM
Inh. Acute 0.1 ppm 30 Hepatic Final 09/97 67-66-3
Int. 0.05 ppm 300 Hepatic Chr. 0.02 ppm 100 Hepatic Oral Acute 0.3 mg/kg/day 100 Hepatic Int. 0.1 mg/kg/day 100 Hepatic Chr. 0.01 mg/kg/day 1000 Hepatic CHLOROMETHANE Inh. Acute 0.5 ppm 100 Neurol. Final 12/98 74-87-3 Int. 0.2 ppm 300 Hepatic Chr. 0.05 ppm 1000 Neurol. 4-CHLOROPHENOL Oral Acute 0.01 mg/kg/day 100 Hepatic Final 07/99 106-48-9 CHLORPYRIFOS Oral Acute 0.003 mg/kg/day 10 Neurol. Final 09/97 2921-88-2 Int. 0.003 mg/kg/day 10 Neurol. Chr. 0.001 mg/kg/day 100 Neurol. CHROMIUM(III) SOLUBLE PARTICULATES Inh. Int. 0.0001 mg/m3 300 Resp. Final 09/12 16065-83-1 CHROMIUM(III) INSOL. PARTICULATES Inh. Int. 0.005 mg/m3 90 Resp. Final 09/12 16065-83-1 CHROMIUM(VI) Oral Int. 0.005 mg/kg/day 100 Hemato. Final 09/12 18540-29-9 Chr. 0.0009 mg/kg/day 100 Gastro. CHROMIUM(VI), AEROSOL MISTS Inh.
0.000005 mg/m3
100 Resp.
09/12 18540-29-9
0.000005 mg/m3
100 Resp.
CHROMIUM(VI), PARTICULATES
0.0003 mg/m3
09/12 18540-29-9
0.0001 mg/m3
7440-48-4
0.01 mg/kg/day
100 Hemato.
Rad. Acute
3 Develop.
Oral Acute
0.01 mg/kg/day
3 Gastro. Final
7440-50-8
0.01 mg/kg/day
3 Gastro.
0.1 mg/kg/day
100 Resp.
1319-77-3
0.1 mg/kg/day
1000 Resp.
CYANIDE, SODIUM
0.05 mg/kg/day
100 Repro.
143-33-9
CYHALOTHRIN
Oral Acute
0.01 mg/kg/day
100 Gastro. Final
09/03 68085-85-8
0.01 mg/kg/day
100 Gastro.
CYPERMETHRIN Oral Acute 0.02 mg/kg/day 100 Neurol. Final 09/03 52315-07-8 DDT, P,P'- Oral Acute
0.0005 mg/kg/day
1000 Develop. Final
0.0005 mg/kg/day
100 Hepatic
DIAZINON
0.01 mg/m3
30 Neurol. Final
333-41-5
Oral Acute
0.006 mg/kg/day
100 Neurol.
0.002 mg/kg/day
100 Neurol.
0.0007 mg/kg/day
100 Neurol.
1,2-DIBROMO-3-CHLOROPROPANE
0.0002 ppm
100 Repro.
0.002 mg/kg/day
1000 Repro.
DI-N-BUTYL PHTHALATE
Oral Acute
0.5 mg/kg/day
100 Develop. Final
1,2-DICHLOROBENZENE
Oral Acute
0.7 mg/kg/day
100 Hepatic Final
0.6 mg/kg/day
100 Hepatic
0.3 mg/kg/day
100 Renal
1,3-DICHLOROBENZENE
Oral Acute
0.4 mg/kg/day
100 Hepatic Final
541-73-1
0.02 mg/kg/day
100 Endocr.
1,4-DICHLOROBENZENE
Inh. Acute
10 Ocular
106-46-7
100 Hepatic
0.07 mg/kg/day
100 Hepatic
0.07 mg/kg/day
100 Hepatic
1,2-DICHLOROETHANE
90 Hepatic Final
107-06-2
0.2 mg/kg/day
300 Renal
1,1-DICHLOROETHENE
100 Hepatic Final
0.009 mg/kg/day
1000 Hepatic
1,2-DICHLOROETHENE, CIS-
Oral Acute
1 mg/kg/day
100 Hemato. Final
156-59-2
0.3 mg/kg/day
100 Hemato.
1,2-DICHLOROETHENE, TRANS-
Inh. Acute
1000 Hepatic Final
156-60-5
1000 Hepatic
0.2 mg/kg/day
100 Hepatic
2,4-DICHLOROPHENOL
0.003 mg/kg/day
100 Immuno. Final
120-83-2
1,2-DICHLOROPROPANE
Inh. Acute 0.05 ppm 1000 Resp. Final 12/89 78-87-5
Int. 0.007 ppm 1000 Resp. Oral Acute 0.1 mg/kg/day 1000 Neurol. Int. 0.07 mg/kg/day 1000 Hemato. Chr. 0.09 mg/kg/day 1000 Hepatic 1,3-DICHLOROPROPENE Inh. Int. 0.008 ppm 30 Resp. Final 09/08 542-75-6 Chr. 0.007 ppm 30 Resp. Oral Int. 0.04 mg/kg/day 100 Gastro. Chr. 0.03 mg/kg/day 100 Gastro. 2,3-DICHLOROPROPENE Inh. Acute 0.002 ppm 90 Resp. Final 09/08 78-88-6 DICHLORVOS Inh. Acute 0.002 ppm 100 Neurol. Final 09/97 62-73-7 Int. 0.0003 ppm 100 Neurol. Chr. 0.00006 ppm 100 Neurol. Oral Acute 0.004 mg/kg/day 1000 Neurol. Int. 0.003 mg/kg/day 10 Neurol. Chr. 0.0005 mg/kg/day 100 Neurol. DIELDRIN Oral Int. 0.0001 mg/kg/day 100 Neurol. Final 09/02 60-57-1 Chr. 0.00005 mg/kg/day 100 Hepatic
DI(2-ETHYLHEXYL)PHTHALATE
0.1 mg/kg/day
100 Repro.
117-81-7
0.06 mg/kg/day
100 Repro.
DIETHYL PHTHALATE
Oral Acute
7 mg/kg/day
300 Repro.
6 mg/kg/day
300 Hepatic
DIISOPROPYL METHYLPHOSPHONATE
0.8 mg/kg/day
100 Hemato. Final
1445-75-6
0.6 mg/kg/day
100 Hemato.
DIMETHYLARSINIC ACID (DMA)
0.02 mg/kg/day
100 Renal
1,1-DIMETHYLHYDRAZINE
0.0002 ppm
300 Hepatic Final
1,2-DIMETHYLHYDRAZINE
0.0008 mg/kg/day
1000 Hepatic Final
540-73-8
1,3-DINITROBENZENE
Oral Acute
0.008 mg/kg/day
100 Repro.
0.0005 mg/kg/day
1000 Hemato.
4,6-DINITRO-O-CRESOL
Oral Acute
0.004 mg/kg/day
100 Neurol. Final
534-52-1
0.004 mg/kg/day
100 Neurol.
2,4-DINITROPHENOL
Oral Acute
0.01 mg/kg/day
100 Body Wt. Final
2,4-DINITROTOLUENE
Oral Acute
0.05 mg/kg/day
100 Neurol. Final
121-14-2
0.002 mg/kg/day
100 Hemato.
2,6-DINITROTOLUENE
0.004 mg/kg/day
1000 Hemato. Final
606-20-2
DI-N-OCTYL PHTHALATE
Oral Acute
3 mg/kg/day
300 Hepatic Final
117-84-0
0.4 mg/kg/day
100 Hepatic
1,4-DIOXANE
Inh. Acute
30 Ocular
123-91-1
300 Resp.
Oral Acute
5 mg/kg/day
100 Develop.
0.5 mg/kg/day
100 Hepatic
0.1 mg/kg/day
100 Hepatic
DISULFOTON
Inh. Acute
0.006 mg/m3
30 Neurol. Final
298-04-4
0.0002 mg/m3
30 Neurol.
Oral Acute
0.001 mg/kg/day
100 Neurol.
0.00009 mg/kg/day
100 Develop.
0.00006 mg/kg/day 1000 Neurol.
ENDOSULFAN
0.005 mg/kg/day
100 Immuno. Final
115-29-7
0.002 mg/kg/day
100 Hepatic
0.002 mg/kg/day
100 Neurol. Final
0.0003 mg/kg/day
100 Neurol.
Oral Acute
0.002 mg/kg/day
30 Neurol. Final
563-12-2
0.002 mg/kg/day
30 Neurol.
0.0004 mg/kg/day
150 Neurol.
ETHYLBENZENE
Inh. Acute
30 Neurol. Final
100-41-4
30 Neurol.
300 Renal
0.4 mg/kg/day
30 Hepatic
ETHYLENE GLYCOL Inh. Acute 2 mg/m3 10 Resp. Final 11/10 107-21-1 Oral Acute 0.8 mg/kg/day 100 Develop. Int. 0.8 mg/kg/day 100 Develop. ETHYLENE OXIDE Inh. Int. 0.09 ppm 100 Renal Final 12/90 75-21-8
FLUORANTHENE
Oral Int. 0.4 mg/kg/day 300 Hepatic Final 08/95 206-44-0
FLUORENE Oral Int. 0.4 mg/kg/day 300 Hepatic Final 08/95 86-73-7 FLUORIDE, SODIUM Oral Chr.
0.05 mg/kg/day
3 Musculo. Final 09/03 7681-49-4
FLUORINE
Inh. Acute
Final 09/03 7782-41-4
FORMALDEHYDE Inh. Acute
Final 07/99 50-00-0
0.008 ppm
0.3 mg/kg/day
100 Gastro.
0.2 mg/kg/day
100 Gastro.
FUEL OIL NO.2
Inh. Acute
0.02 mg/m3
1000 Neurol. Final
06/95 68476-30-2
GUTHION (AZINPHOS-METHYL)
Inh. Acute
0.02 mg/m3
30 Neurol. Final
0.01 mg/m3
30 Neurol.
0.01 mg/m3
30 Neurol.
Oral Acute
0.01 mg/kg/day
100 Neurol.
0.003 mg/kg/day
100 Neurol.
0.003 mg/kg/day
100 Neurol.
HEPTACHLOR
Oral Acute
0.0006 mg/kg/day
3000 Repro.
0.0001 mg/kg/day
300 Immuno.
HEXACHLOROBENZENE
Oral Acute
0.008 mg/kg/day
300 Develop. Final
118-74-1
0.0001 mg/kg/day
90 Repro.
0.00005 mg/kg/day
300 Develop.
HEXACHLOROBUTADIENE
0.0002 mg/kg/day
1000 Renal
ALPHA-HEXACHLOROCYCLOHEXANE
0.008 mg/kg/day
100 Hepatic Final
319-84-6
BETA-HEXACHLOROCYCLOHEXANE
Oral Acute
0.05 mg/kg/day
100 Neurol. Final
319-85-7
0.0006 mg/kg/day
300 Hepatic
GAMMA-HEXACHLOROCYCLOHEXANE
Oral Acute
0.003 mg/kg/day
300 Develop. Final
0.00001 mg/kg/day 1000 Immuno.
HEXACHLOROCYCLOPENTADIENE
0.0002 ppm
0.1 mg/kg/day
100 Renal
HEXACHLOROETHANE
Inh. Acute 6 ppm 30 Neurol. Final 09/97 67-72-1
Int. 6 ppm 30 Neurol. Oral Acute 1 mg/kg/day 100 Hepatic Int. 0.01 mg/kg/day 100 Hepatic HEXAMETHYLENE DIISOCYANATE Inh. Int. 0.00003 ppm 30 Resp. Final 10/98 822-06-0 Chr. 0.00001 ppm 90 Resp. N-HEXANE Inh. Chr. 0.6 ppm 100 Neurol. Final 07/99 110-54-3 HMX (CYCLOTETRAMETHYLENE Oral Acute 0.1 mg/kg/day 1000 Neurol. Final 09/97 2691-41-0 TETRANITRAMINE) Int. 0.05 mg/kg/day 1000 Hepatic HYDRAZINE Inh. Int. 0.004 ppm 300 Hepatic Final 09/97 302-01-2 HYDROGEN FLUORIDE Inh. Acute 0.02 ppm 30 Resp. Final 09/03 7664-39-3 HYDROGEN SULFIDE Inh. Acute 0.07 ppm 27 Resp. Final 07/06 7783-06-4 Int. 0.02 ppm 30 Resp. IODIDE Oral Acute
0.01 mg/kg/day
1 Endocr. Final
7553-56-2
0.01 mg/kg/day
1 Endocr.
IONIZING RADIATION, N.O.S.
Rad. Acute
3 Neurol. Final 09/99 HZ1800-45-T
ISOPHORONE
3 mg/kg/day
100 Other
0.2 mg/kg/day
1000 Hepatic
300 Hepatic Final
06/95 50815-00-4
JP-5/JP-8
300 Hepatic Final 10/98 HZ0600-26-T
0.3 mg/m3
300 Hepatic Final 06/95 HZ0600-22-T
KEROSENE
0.01 mg/m3
1000 Hepatic Final
8008-20-6
MALATHION
Inh. Acute
0.2 mg/m3
100 Neurol. Final
121-75-5
0.02 mg/m3
1000 Resp.
0.02 mg/kg/day
10 Neurol.
0.02 mg/kg/day
100 Neurol.
MANGANESE, RESPIRABLE
0.3 ug/m3
100 Neurol. Final
7439-96-5
MERCURIC CHLORIDE
Oral Acute
0.007 mg/kg/day
100 Renal
7487-94-7
0.002 mg/kg/day
100 Renal
0.0002 mg/m3
30 Neurol. Final
7439-97-6
METHOXYCHLOR
0.005 mg/kg/day
1000 Repro.
4,4'-METHYLENEBIS(2-CHLOROANILINE) Oral
0.003 mg/kg/day
3000 Hepatic Final
101-14-4
METHYLENE CHLORIDE
Inh. Acute
100 Neurol. Final
90 Hepatic
30 Hepatic
Oral Acute
0.2 mg/kg/day
100 Neurol.
0.06 mg/kg/day
100 Hepatic
4,4'-METHYLENEDIANILINE
Oral Acute
0.2 mg/kg/day
300 Hepatic Final
101-77-9
0.08 mg/kg/day
100 Hepatic
METHYLMERCURY
0.0003 mg/kg/day
4.5 Develop. Final
03/99 22967-92-6
1-METHYLNAPHTHALENE
0.07 mg/kg/day
1000 Resp.
2-METHYLNAPHTHALENE
0.04 mg/kg/day
100 Resp.
METHYL PARATHION
0.0007 mg/kg/day
300 Neurol. Final
298-00-0
0.0003 mg/kg/day
100 Hemato.
METHYL-T-BUTYL ETHER
Inh. Acute
100 Neurol. Final
1634-04-4
100 Neurol.
100 Renal
Oral Acute
0.4 mg/kg/day
100 Neurol.
0.3 mg/kg/day
300 Hepatic
0.0008 mg/kg/day
100 Hepatic Final
2385-85-5
MONOMETHYLARSONIC ACID
0.1 mg/kg/day
100 Gastro. Final
124-58-3
0.01 mg/kg/day
100 Renal
NAPHTHALENE
0.0007 ppm
300 Resp.
Oral Acute
0.6 mg/kg/day
90 Neurol.
0.6 mg/kg/day
90 Neurol.
N-NITROSODI-N-PROPYLAMINE
Oral Acute
0.095 mg/kg/day
100 Hepatic Final
621-64-7
Inh. Int. 0.0002 mg/m3 30 Resp. Final 09/05 7440-02-0
Chr. 0.00009 mg/m3 30 Resp. 2,3,4,7,8-PENTACHLORODIBENZOFURAN Oral Acute 0.001 ug/kg/day 3000 Immuno. Final 05/94 57117-31-4 Int. 0.00003 ug/kg/day 3000 Hepatic PENTACHLOROPHENOL Oral Acute 0.005 mg/kg/day 1000 Develop. Final 09/01 87-86-5 Int. 0.001 mg/kg/day 1000 Repro. Chr. 0.001 mg/kg/day 1000 Endocr. PERCHLORATES Oral Chr. 0.0007 mg/kg/day 10 Endocr. Final 08/08 7778-74-7 PERMETHRIN Oral Acute 0.3 mg/kg/day 100 Neurol. Final 09/03 52645-53-1 Int. 0.2 mg/kg/day 100 Neurol. PHENOL Oral Acute 1 mg/kg/day 100 Body Wt. Final 09/08 108-95-2 PHOSPHORUS, WHITE Inh. Acute 0.02 mg/m3 30 Resp. Final 09/97 7723-14-0 Oral Int. 0.0002 mg/kg/day 100 Repro. POLYBROMINATED BIPHENYLS (PBBs) Oral Acute 0.01 mg/kg/day 100 Endocr. Final 10/04 36355-01-8 POLYBROMINATED DIPHENYL ETHERS Inh Int.
0.006 mg/m3
90 Endocr. Final
10/04 32534-81-9
(PBDEs), LOWER BROMINATED
Oral Acute
0.03 mg/kg/day
30 Endocr.
32536-52-0
0.007 mg/kg/day
300 Hepatic
PBDEs, DECABROMINATED
10 mg/kg/day
100 Develop. Final
1163-19-5
POLYCHLORINATED BIPHENYLS (PCBs)
0.03 ug/kg/day
300 Neurol. Final
11/00 11097-69-1
(Aroclor 1254)
0.02 ug/kg/day
300 Immuno.
PROPYLENE GLYCOL
0.009 ppm
1000 Resp.
PROPYLENE GLYCOL DINITRATE
Inh. Acute
0.003 ppm
10 Neurol. Final
6423-43-4
0.00004 ppm
1000 Hemato.
0.00004 ppm
1000 Hemato.
RDX (Cyclonite)
Oral Acute
0.2 mg/kg/day
30 Neurol. Final
121-82-4
0.1 mg/kg/day
30 Neurol.
0.1 mg/kg/day
30 Neurol.
REFRACTORY CERAMIC FIBERS
0.03 fibers/cc
Final 10/04 HZ0900-26-T
SELENIUM
0.005 mg/kg/day
7782-49-2
STRONTIUM Oral Int. 2 mg/kg/day 30 Musculo. Final 10/04 7440-24-6 STYRENE Inh. Acute 5 ppm 10 Neurol. Final 11/10 100-42-5 Chr. 0.2 ppm 30 Neurol. Oral Acute 0.1 mg/kg/day 1000 Neurol. SULFUR DIOXIDE Inh. Acute 0.01 ppm 9 Resp. Final 12/98 7446-09-5 SULFUR MUSTARD Inh. Acute 0.0007 mg/m3 30 Ocular Final 09/03 505-60-2 Int. 0.00002 mg/m3 30 Ocular Oral Acute 0.5 ug/kg/day 1000 Develop. Int. 0.07 ug/kg/day 300 Gastro. 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN Oral Acute 0.0002 ug/kg/day 21 Immuno. Final 12/98 1746-01-6 Int. 0.00002 ug/kg/day 30 Lymphor. Chr. 0.000001 ug/kg/day 90 Develop. 1,1,2,2-TETRACHLOROETHANE Oral Int. 0.5 mg/kg/day 100 Hepatic Final 09/08 79-34-5 TETRACHLOROETHYLENE Inh. Acute 0.2 ppm 10 Neurol. Final 09/97 127-18-4 Chr. 0.04 ppm 100 Neurol. Oral Acute 0.05 mg/kg/day 100 Develop. TIN, INORGANIC Oral Int. 0.3 mg/kg/day 100 Hemato. Final 09/05 7440-31-5 TIN, DIBUTYL-, DICHLORIDE Oral Int. 0.005 mg/kg/day 1000 Immuno. Final 09/05 683-18-1 TIN, TRIBUTYL-, OXIDE Oral Int. 0.0003 mg/kg/day 100 Immuno. Final 09/05 56-35-9 Chr. 0.0003 mg/kg/day 100 Immuno. TITANIUM TETRACHLORIDE Inh. Int. 0.01 mg/m3 90 Resp. Final 09/97 7550-45-0 Chr. 0.0001 mg/m3 90 Resp. TOLUENE Inh. Acute 1 ppm 10 Neurol. Final 09/00 108-88-3 Chr. 0.08 ppm 100 Neurol. Oral Acute 0.8 mg/kg/day 300 Neurol. Int. 0.02 mg/kg/day 300 Neurol. TOXAPHENE Oral Acute 0.05 mg/kg/day 100 Neurol. Draft 09/10 8001-35-2 Int. 0.002 mg/kg/day 100 Immuno. TRIBUTYL PHOSPHATE Oral Acute 1.1 mg/kg/day 100 Body Wt. Final 09/12 126-73-8 (TnBP) Int. 0.08 mg/kg/day 100 Renal
Chr. 0.08 mg/kg/day 100 Renal 1,2,4-TRICHLOROBENZENE Oral Int. 0.1 mg/kg/day 100 Hepatic Draft 9/10 120-82-1 Chr. 0.1 mg/kg/day 100 Hepatic 1,1,1-TRICHLOROETHANE Inh. Acute 2 ppm 100 Neurol. Final 07/06 71-55-6 Int. 0.7 ppm 100 Neurol. Oral Int. 20 mg/kg/day 100 Body Wt. 1,1,2-TRICHLOROETHANE Oral Acute 0.3 mg/kg/day 100 Neurol. Final 12/89 79-00-5 Int. 0.04 mg/kg/day 100 Hepatic TRICHLOROETHYLENE Inh. Chr. 0.0004 ppm 10 Develop. Addendum 01/13 79-01-6 100 Immuno. Oral Chr. 0.0005 mg/kg/day 10 Develop. 100 Immuno. 1000 Immuno. 1,2,3-TRICHLOROPROPANE Inh. Acute 0.0003 ppm 100 Resp. Final 09/92 96-18-4 Oral Int. 0.08 mg/kg/day 100 Hepatic TRICRESYL PHOSPHATE Oral Int. 0.04 mg/kg/day 100 Reprod. Final 09/12 1330-78-5 (TCP) Chr. 0.02 mg/kg/day 100 Reprod. 2,4,6-TRINITROTOLUENE Oral Int.
0.0005 mg/kg/day
1000 Hepatic
Final 06/95
118-96-7
TRIS(2-BUTOXYETHYL) PHOSPHATE
Oral Acute
4.8 mg/kg/day
100 Body Wt. Final 09/12
0.09 mg/kg/day
100 Hepatic
TRIS(2-CHLOROETHYL) PHOSPHATE
0.6 mg/kg/day
100 Neurol.
Final 09/12
115-96-8
0.2 mg/kg/day
100 Renal
TRIS(1,3-DICHLORO-2-PROPYL)
0.05 mg/kg/day
100 Renal
Final 09/12 13674-87-8
PHOSPHATE (TDCP)
0.02 mg/kg/day
100 Renal
URANIUM, SOLUBLE SALTS
0.0001 mg/m3
300 Renal
Draft 05/11
7440-61-1
0.00004 mg/m3
100 Renal
Oral Acute
0.002 mg/kg/day
100 Develop.
0.0002 mg/kg/day
300 Renal
URANIUM, INSOLUBLE COMPOUNDS
0.002 mg/m3
100 Renal
Draft 05/11
7440-61-1
0.0008 mg/m3
1000 Resp.
VANADIUM
Inh. Acute
0.0008 mg/m3
7440-62-2
0.0001 mg/m3
0.01 mg/kg/day
10 Hemato.
VINYL ACETATE
100 Resp.
108-05-4
VINYL CHLORIDE
Inh. Acute
30 Develop. Final
30 Hepatic
0.003 mg/kg/day
30 Hepatic
XYLENES, MIXED
Inh. Acute
30 Neurol. Final
1330-20-7
90 Neurol.
300 Neurol.
Oral Acute
1 mg/kg/day
100 Neurol.
0.4 mg/kg/day
1000 Neurol.
0.2 mg/kg/day
1000 Neurol.
0.3 mg/kg/day
3 Hemato. Final
7440-66-6
0.3 mg/kg/day
3 Hemato.
______________________________________________________________________________________________________________
Total number of MRLs: 399
For Duration, Acute = 1 to 14 days, Intermediate = 15 to 364 days, and Chronic = 1 year or longer.
For general information on ATSDR Minimal Risk Levels, see www.atsdr.cdc.gov/mrls.
For more information on a specific MRL, please refer to our Toxicological Profiles,
particularly Appendix A of Profiles written after 1995.
The Profiles can be found online at www.astdr.cdc.gov or ordered via [email protected] or 1-800-CDC-INFO.
Source: http://laperouse.info/wordpress/wp-content/uploads/2010/08/ATSDR-Minimum-Risk-Levels-2013.pdf
AWMF online - Leitlinie Neurologie: Hirnmetastasen AWMF online A rbeitsgemeinschaft der W issenschaftlichen M edizinischen F achgesellschaften Leitlinien der Deutschen Gesellschaft für Neurologie AWMF-Leitlinien-Register Nr. 030/043 Entwicklungsstufe: 1 Zitierbare Quelle: Leitlinien für Diagnostik und Therapie in der Neurologie; 3. überarbeitete Auflage 2005, I
TREATMENT REVIEW Diagnostic and Therapeutic Utility of B-Type Natriuretic Peptide in Patients With Renal Insufficiency and Decompensated Heart Failure Peter A. McCullough, MD, MPH, FACC, FACP, FCCP FAHA,* Kuncheria Joseph, MD,† Vandana S. Mathur, MD‡*Divisions of Cardiology, Nutrition and Preventive Medicine, William Beaumont Hospital, RoyalOak, MI, †Bon Secours Hospital, Venice, FL,
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z |
0-9 |